Literature DB >> 20542955

Signaling from membrane receptors to tumor suppressor WW domain-containing oxidoreductase.

Jean-Yun Chang1, Ruei-Yu He, Hsin-Ping Lin, Li-Jin Hsu, Feng-Jie Lai, Qunying Hong, Shean-Jen Chen, Nan-Shan Chang.   

Abstract

The family of WW domain-containing proteins contains over 2000 members. The small WW domain module is responsible, in part, for protein/protein binding interactions and signaling. Many of these proteins are located at the membrane/cytoskeleton area, where they act as adaptors to receive signals from the cell surface. In this review, we provide molecular insights regarding recent novel findings on signaling from the cell surface toward WW domain-containing oxidoreductase, known as WWOX, FOR or WOX1. More specifically, transforming growth factor beta 1 utilizes cell surface hyaluronidase Hyal-2 (hyaluronoglucosaminidase 2) as a cognate receptor for signaling with WWOX and Smad4 to control gene transcription, growth and death. Complement C1q alone, bypassing the activation of classical pathway, signals a novel event of apoptosis by inducing microvillus formation and WWOX activation. Deficiency in these signaling events appears to favorably support cancer growth.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20542955     DOI: 10.1258/ebm.2010.009351

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  31 in total

Review 1.  Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events.

Authors:  Shenq-Shyang Huang; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-08

2.  Downregulation of WW domain-containing oxidoreductase leads to tamoxifen-resistance by the inactivation of Hippo signaling.

Authors:  Juan Li; Xuefei Feng; Canyu Li; Jie Liu; Pingping Li; Ruiqi Wang; He Chen; Peijun Liu
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-02

3.  Zfra induction of memory anticancer response via a novel immune cell.

Authors:  Wan-Pei Su; Wan-Jan Wang; Chun-I Sze; Nan-Shan Chang
Journal:  Oncoimmunology       Date:  2016-07-28       Impact factor: 8.110

Review 4.  Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.

Authors:  Shin-Yi Liu; Ming-Fu Chiang; Yu-Jen Chen
Journal:  Exp Biol Med (Maywood)       Date:  2014-11-27

Review 5.  Decoding the link between WWOX and p53 in aggressive breast cancer.

Authors:  Suhaib K Abdeen; Rami I Aqeilan
Journal:  Cell Cycle       Date:  2019-05-16       Impact factor: 4.534

6.  Identification of an In Vivo MEK/WOX1 Complex as a Master Switch for Apoptosis in T Cell Leukemia.

Authors:  Hsin-Ping Lin; Jean-Yun Chang; Sing-Ru Lin; Ming-Hui Lee; Shenq-Shyang Huang; Li-Jin Hsu; Nan-Shan Chang
Journal:  Genes Cancer       Date:  2011-05

Review 7.  The fragile site WWOX gene and the developing brain.

Authors:  Brahim Tabarki; Fuad Al Mutairi; Amal Al Hashem
Journal:  Exp Biol Med (Maywood)       Date:  2014-11-21

Review 8.  Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductase.

Authors:  Yao Chang; Yu-Yan Lan; Jenn-Ren Hsiao; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-07

Review 9.  Emerging roles for hyaluronidase in cancer metastasis and therapy.

Authors:  Caitlin O McAtee; Joseph J Barycki; Melanie A Simpson
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

10.  Role of WW Domain-containing Oxidoreductase WWOX in Driving T Cell Acute Lymphoblastic Leukemia Maturation.

Authors:  Shenq-Shyang Huang; Wan-Pei Su; Hsin-Pin Lin; Hsiang-Ling Kuo; Hsiao-Ling Wei; Nan-Shan Chang
Journal:  J Biol Chem       Date:  2016-06-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.